118 related articles for article (PubMed ID: 16253865)
1. Weeding out new drugs.
Ewan S
Drug Discov Today; 2005 Oct; 10(20):1336-7. PubMed ID: 16253865
[No Abstract] [Full Text] [Related]
2. Is the cannabinoid CB1 receptor antagonist rimonabant advancing the treatment of obesity?
Doggrell SA
Expert Opin Pharmacother; 2005 Oct; 6(12):2141-4. PubMed ID: 16197364
[No Abstract] [Full Text] [Related]
3. Cannabinoids and cardiovascular disease: the outlook for clinical treatments.
Ashton JC; Smith PF
Curr Vasc Pharmacol; 2007 Jul; 5(3):175-85. PubMed ID: 17627561
[TBL] [Abstract][Full Text] [Related]
4. Novel antiobesity agents: synthesis and pharmacological evaluation of analogues of Rimonabant and of LH21.
Alvarado M; Decara J; Luque MJ; Hernandez-Folgado L; Gómez-Cañas M; Gómez-Ruiz M; Fernández-Ruiz J; Elguero J; Jagerovic N; Serrano A; Goya P; de Fonseca FR
Bioorg Med Chem; 2013 Apr; 21(7):1708-16. PubMed ID: 23434135
[TBL] [Abstract][Full Text] [Related]
5. End of the line for cannabinoid receptor 1 as an anti-obesity target?
Jones D
Nat Rev Drug Discov; 2008 Dec; 7(12):961-2. PubMed ID: 19043439
[TBL] [Abstract][Full Text] [Related]
6. High hopes for cannabinoid analgesia.
Watts G
BMJ; 2004 Jul; 329(7460):257-8. PubMed ID: 15258005
[No Abstract] [Full Text] [Related]
7. [Pharmacology of cannabinoid receptors].
Le Fur G; Rinaldi-Carmona M; Barth F; Alexander J
Bull Acad Natl Med; 2007; 191(4-5):933-8; discussion 938-40. PubMed ID: 18225447
[TBL] [Abstract][Full Text] [Related]
8. Play an ADAGIO with a STRADIVARIUS: the right patient for CB1 receptor antagonists?
Di Marzo V
Nat Clin Pract Cardiovasc Med; 2008 Oct; 5(10):610-2. PubMed ID: 18695695
[No Abstract] [Full Text] [Related]
9. Rimonabant Sanofi-Synthélabo.
Fernandez JR; Allison DB
Curr Opin Investig Drugs; 2004 Apr; 5(4):430-5. PubMed ID: 15134285
[TBL] [Abstract][Full Text] [Related]
10. Molecule of the month. Rimonabant hydrochloride.
Drug News Perspect; 2004; 17(6):403. PubMed ID: 15334190
[No Abstract] [Full Text] [Related]
11. Rimonabant, obesity and diabetes.
Prescrire Int; 2007 Jun; 16(89):122. PubMed ID: 17585427
[TBL] [Abstract][Full Text] [Related]
12. [Endocannabinoids: therapeutic perspectives in chronic liver diseases].
Lotersztajn S; Teixeira-Clerc F; Hezode C; Tran van Nhieu J; Deveaux V; Mallat A
Gastroenterol Clin Biol; 2007 Mar; 31(3):255-8. PubMed ID: 17396081
[No Abstract] [Full Text] [Related]
13. Medical cannabis vs. synthetic cannabinoids: What does the future hold?
Bolognini D; Ross RA
Clin Pharmacol Ther; 2015 Jun; 97(6):568-70. PubMed ID: 25761845
[TBL] [Abstract][Full Text] [Related]
14. Methylsulfonylpyrazolyl oxadiazoles and thiadiazoles as potent, orally bioavailable cannabinoid-1 receptor antagonists for the treatment of obesity.
Seo HJ; Kim MJ; Song KS; Lee SH; Jung ME; Kim MS; Park HJ; Yoo J; Chang CH; Kim J; Lee J
Future Med Chem; 2009 Aug; 1(5):947-67. PubMed ID: 21426091
[TBL] [Abstract][Full Text] [Related]
15. Long term cannabinoid receptor (CB1) blockade in obesity: implications for the development of colorectal cancer.
Wright KL; Robertson DA; Moyer MP; Ward SG
Int J Cancer; 2008 Apr; 122(8):1920-1. PubMed ID: 18076045
[No Abstract] [Full Text] [Related]
16. Endocannabinoid signalling as an anti-inflammatory therapeutic target in atherosclerosis: does it work?
Immenschuh S
Cardiovasc Res; 2009 Dec; 84(3):341-2. PubMed ID: 19819883
[No Abstract] [Full Text] [Related]
17. Cannabis antagonists: a new era of social psychopharmacology?
Nutt D
J Psychopharmacol; 2005 Jan; 19(1):3-4. PubMed ID: 15671122
[No Abstract] [Full Text] [Related]
18. End of the line for cannabinoid receptor 1 as an anti-obesity target? An opinion.
Bifulco M; Pisanti S
Nat Rev Drug Discov; 2009 Jul; 8(7):594. PubMed ID: 19568284
[No Abstract] [Full Text] [Related]
19. Immunoactive effects of cannabinoids: considerations for the therapeutic use of cannabinoid receptor agonists and antagonists.
Greineisen WE; Turner H
Int Immunopharmacol; 2010 May; 10(5):547-55. PubMed ID: 20219697
[TBL] [Abstract][Full Text] [Related]
20. The Therapeutic Potential of Cannabis in Counteracting Oxidative Stress and Inflammation.
Graczyk M; Lewandowska AA; Dzierżanowski T
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
